Partner Headlines - GSK

  1. China Fines Glaxo For Bribes

    IBD
  2. Guru Stocks at 52-Week Lows: BHP, GSK, VOD, LYG, TEF

    GuruFocus
  3. Stock Futures Down, But Not Far; Alibaba Sets IPO Price Range

    IBD
  4. Benzinga's M&A Chatter for Wednesday August 27, 2014

    Benzinga
  5. GSK Receives FDA Approval Of An Additional Promacta (eltrombopag) ...

    Benzinga
  6. InterMune Stock Spikes On Rare Big Biotech Buyout

    IBD
  7. 3 Dividend Kings From The U.K. I Love To Buy

    GuruFocus
  8. UPDATE: GlaxoSmithKline Receives FDA Approval For Arnuity Ellipta ...

    Benzinga
  9. Guru Stocks at 52-Week Lows: PFE, GSK, VOD, EC, MFG

    GuruFocus
  10. Intermune up on buyout buzz

    IBD
  11. You Should Consider Adding GlaxoSmithKline Based on Tremendous ...

    GuruFocus
  12. Drugmaker AstraZeneca Returns To Growth

    IBD
  13. Widely Held Guru Stocks Near 52-Week Lows

    GuruFocus
  14. Pfizer To Buy Baxter's Vaccines For $635 Million: The Positives ...

    Benzinga
  15. Glaxo, Sanofi Trend Up On Potential Deal For Established Brands

    Benzinga
  16. Guru Stocks at 52-Week Lows: PFE, GSK, VOD, EC, UBS

    GuruFocus
  17. Glaxo, Genmab Report Positive Interim Result for Phase III Study ...

    Benzinga
  18. A Look at the Week's Top Dividend Growers

    GuruFocus
  19. Markets Little Changed Ahead Of The Federal Reserve's Policy ...

    Benzinga
  20. GlaxoSmithKline

    IBD
  21. Stock Futures Up, But Wobbly; Boeing, Apple, Biogen Rising

    IBD
  22. Mylan Wins Motion To Enjoin GlaxoSmithKline From Providing Paroxetine ...

    Benzinga
  23. Morning Market Movers

    Benzinga
  24. Top 4 NYSE Stocks In The Drug Manufacturers-Major Industry With ...

    Benzinga
  25. Highest Yielding Stocks Widely Held By The Gurus

    GuruFocus
  26. British Stocks: Sweet Spot For European Value

    YCharts
  27. Diamond Hill Capital Comments on GlaxoSmithKline PLC

    GuruFocus
  28. ISIS Pharma Trades Up Premarket; NYT Says Has Potential Heart ...

    Benzinga
  29. Advances In HIV, Hep C Treatments Could Spark Renewed Interest ...

    Benzinga
  30. InterMune Up On Bullish View Of U.S. Esbriet Launch

    IBD
  31. UPDATE: Glaxo, Theravance Report Positive Data from Two Studies ...

    Benzinga
  32. Major British Companies Lead Top Guru-Held UK and Ireland Stocks ...

    GuruFocus
  33. ASCO Meeting Day 3: Do More Treatments Equal A Longer Life?

    Benzinga
  34. ASCO Meeting Day 2: 'Promising' Results From JNJ's Imbruvica ...

    Benzinga
  35. Aura Of Light Shines On Pernix Shares Following Treximet Acquisition

    Benzinga
  36. Cross-Border Megamergers Drive Global Takeover Boom

    IBD
  37. Google Celebrates Dorothy Hodgkin & Her Contributions To Chemistry

    Benzinga
  38. Can Pfizer Make Up Its Loss?

    GuruFocus
  39. Merck Sells Consumer Unit To Bayer To Focus On R&D

    IBD
  40. Bayer Buys Merck Consumer Care Unit

    FoxBusiness
  41. AstraZeneca Rejects Pfizer's $106B Buyout Bid

    FoxBusiness
  42. #PreMarket Primer: Thursday, May 1: Fed Brushes Off Dissapointing ...

    Benzinga
  43. Glaxo hurt by Advair scandal

    IBD
  44. Nasdaq Leads Early Stock Slide; Twitter Tumbles, Trinity Rises

    IBD
  45. Stock Futures Slip as Traders Brace for Economic Flood

    FoxBusiness
  46. Disappointing GDP Reading Weighs on Stocks

    FoxBusiness
  47. China Rule Change Further Opens Yuan To World Markets

    IBD
  48. Weekly 52-Week Highs Highlight: AV, XEL, OKE, GSK

    GuruFocus
  49. GSK, MMV Announce Commencement of Phase III Programme of Tafenoquine ...

    Benzinga
  50. These Three Pharmaceutical Companies Shake The Market With Their ...

    GuruFocus
  51. Benzinga Weekly Preview: Earnings Season Continues As Biotech ...

    Benzinga
  52. Big Pharmas Swap Specialties

    IBD
  53. Drugmakers Prod European Stocks To Post-Easter Rally

    IBD
  54. Valeant's Bid For Allergan Boosts Ethical Drug Stocks

    IBD
  55. Novartis, Glaxo Swap Units; Valeant Bids For Allergan

    IBD
  56. Stocks Rise In Higher Volume; Gilead Up After Hours

    IBD
  57. S&P 500, Nasdaq Rise For Sixth Day As Volume Picks Up

    IBD
  58. Pharma Deal Frenzy: A Bid to Boost Profits, Cut Risk

    FoxBusiness
  59. Amgen Slumps After 1Q Earnings Miss

    FoxBusiness
  60. Drug ETFs Surge On M&A Activity (AGN, VRX, IHE, XPH, PPH, AZN)

    Benzinga
  61. Novartis, Glaxo Swap Units; Lilly Buying Animal Biz

    IBD
  62. Stock Futures Mixed And Busy; Allergan, Netflix, Glaxo Climb

    IBD
  63. Novartis Announces Multi-Billion-Dollar Revamp

    FoxBusiness
  64. US Stock Futures Edge Higher Ahead Of McDonald's Earnings

    Benzinga
  65. Stock Futures Steady Amid Raft of Health M&A

    FoxBusiness
  66. Wall Street Ticks Up as Traders Parse News Deluge

    FoxBusiness
  67. GlaxoSmithKline Finally Received Approval from FDA for Its Diabetes ...

    GuruFocus
  68. Has A Streamlined FDA Raised The Value Of Drug Stocks?

    IBD
  69. Pharmaceutical Stocks For Income, Value, And Growth Investors

    Benzinga
  70. New Glaxo bribery inquiries

    IBD
  71. Race for Vaccines, Treatments as West Africa Ebola Death Toll ...

    Benzinga
  72. Top 4 NYSE Stocks In The Drug Manufacturers-Major Industry With ...

    Benzinga
  73. GlaxoSmithKline

    IBD
  74. Amgen, GSK End Marketing Pact for Osteoporosis Drug

    FoxBusiness
  75. Biotech Auxilium Boosts Position In Men's Health Care

    IBD
  76. Glaxosmithkline Confirms Warning Letter Received from FDA o March ...

    Benzinga
  77. GSK buys up Indonesia unit

    IBD
  78. GSK Recalls Alli in U.S. After Package Tampering

    FoxBusiness
  79. GSK, FDA Probe Tampering of Weight-Loss Drug Alli

    FoxBusiness
  80. Which Pharmas Can Keep Up Dividend-Buybacks?

    YCharts
  81. Market Wrap For March 20: Investors Showing No Post-Fed Decision ...

    Benzinga
  82. Glaxo Cancer Vaccine Fails, Testing Continues

    FoxBusiness
  83. Morning Market Losers

    Benzinga
  84. US Stock Futures Drop Ahead Of Jobless Claims Report

    Benzinga
  85. Agenus Therapeutics Reports GlaxoSmithKline's Magrit Study Does ...

    Benzinga
  86. T. Rowe Price's Brian Rogers Joins GuruFocus for Q&A - Ask an ...

    GuruFocus
  87. T. Rowe Price CIO Brian Rogers Joins GuruFocus for Q&A - Ask ...

    GuruFocus
  88. Gilead's HCV Challengers Near The Starting Gate

    IBD
  89. Brian Rogers of T. Rowe Price Joins GuruFocus for Q&A - Ask a ...

    GuruFocus
  90. Gilead's HCV Challengers Near The Starting Gate

    IBD
  91. Prosensa Muscular Dystrophy Data Send Stock Rising

    IBD
  92. A HIV shot could replace pills

    IBD
  93. Why Long-Term Investor Warren Buffett's Company Just Sold 2 Stocks

    GuruFocus
  94. GlaxoSmithKline, Kinder Morgan And Others Insiders Have Been ...

    Benzinga
  95. Glaxo's COPD Drug Gets European Green Light

    FoxBusiness
  96. Berkshire Hathaway Files SEC 13F

    Benzinga
  97. Pharmacyclics' Imbruvica Wins Second Cancer Approval

    IBD
  98. Novartis' 'Cliffy' Business

    GuruFocus
  99. Glaxo expects to retain lead

    IBD
  100. Benzinga Weekly Preview: Twitter To Release Earnings For The ...

    Benzinga
Trading Center